Upcoming Earnings Reports for Cannabis Companies
The earnings season is gearing up, and it brings with it the opportunity to gain insights into the financial health of key players in the cannabis industry. Two prominent companies that will be reporting soon are AFC Gamma, Inc. (NASDAQ: AFCG) and Ascend Wellness Holdings, Inc. (CSE: AAWH, OTCQX: AAWH). Both companies are leading lenders in the cannabis sector, making their earnings calls particularly significant for investors and industry watchers alike.
AFC Gamma, Inc.
AFC Gamma, Inc. is scheduled to report its earnings for the quarter ending September 30, 2024, on November 13, 2024. The company will follow up its financial results with a conference call at 10:00 am ET on the same day, allowing stakeholders to gain an understanding of its performance and future outlook.
Positioned as a major player in cannabis lending, AFC Gamma stands out as one of only two major externally managed real estate investment trusts (REITs) focused on this industry. The company's unique position results from the challenges cannabis operations face in accessing capital due to the federal status of cannabis.
Recently, AFC Gamma's loan portfolio has shown promising growth, with four new deals amounting to over $70 million secured in just a few months. These transactions include significant loans for companies such as Sunburn Cannabis, SocietyC, and Gron Edibles. Such activity underscores both the demand for capital in the cannabis sector and AFC Gamma's pivotal role in meeting that demand.
As for its financial returns, AFC Gamma recently declared a quarterly dividend of $0.33 per share, set to be paid on October 15, 2024, marking a significant milestone in its post-spin-off phase.
Ascend Wellness Holdings, Inc.
Likewise, Ascend Wellness (CSE: AAWH, OTCQX: AAWH) will be releasing its earnings on November 12, 2024, and will hold a conference call at 8:30 am ET. This call is highly anticipated as the company has shown substantial revenue growth, reporting $141.54 million for the last quarter ending June 30, 2024, in contrast to $122.99 million the previous year.
The shift in leadership at Ascend Wellness is noteworthy, as Samuel Brill steps in as CEO, following the tenure of John Hartmann. Brill is expected to steer the company through its recent refinancing processes effectively, aiming for a stronger financial future.
The company is further establishing its strength in the market by recently closing a $235 million private placement of senior secured notes due in 2029. The proactive measures taken by Ascend Wellness indicate a commitment to long-term growth and sustainability.
Impact on the Cannabis Sector
The upcoming earnings reports from AFC Gamma and Ascend Wellness are crucial events that will shed light on the overall health of the cannabis financial landscape. As these companies navigate the challenges of a federally restricted environment, their strategies in securing financing and managing growth will serve as essential indicators for investors.
What Lies Ahead for Investors?
Investors should prepare for the anticipated calls by reviewing previous performance metrics and market trends. With AFC Gamma's innovative financing solutions and Ascend Wellness’s robust growth, there’s much to discuss. Automating financing access in a mostly challenging environment can potentially lead to significant returns for investors looking to delve into the cannabis industry.
Frequently Asked Questions
When will AFC Gamma report its earnings?
AFC Gamma will report its earnings for the quarter ending September 30, 2024, on November 13, 2024.
What significant growth has AFC Gamma achieved recently?
AFC Gamma has executed new loan deals totaling over $70 million within a short timeframe, demonstrating its growth in the sector.
How has Ascend Wellness performed in recent quarters?
Ascend Wellness reported $141.54 million in revenue for the second quarter of 2024, showing year-over-year growth.
What changes occurred in Ascend Wellness's management?
Samuel Brill has recently taken over as CEO of Ascend Wellness, replacing John Hartmann.
How important are these earnings reports for investors?
These earnings reports provide crucial insights into the financial health and strategic direction of these key players in the cannabis industry, making them vital for investment decisions.
